ArticleEnvironmental pollution (Barking, Essex : 1987)2025
Associations between urinary polycyclic aromatic hydrocarbon biomarker concentrations and birth outcomes in the LIFECODES cohort.
Article in Environmental pollution (Barking, Essex : 1987), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Environmental exposure to polycyclic aromatic hydrocarbons (PAH) is ubiquitous and may impact fetal development leading to adverse birth outcomes. PAHs result from incomplete combustion and exposure sources include inhalation of cigarette smoke and car exhaust, ingestion of charred meat, and many others. The purpose of this study was to determine associations between prenatal PAH biomarker concentrations and birth outcomes. Our nested case-control study included 123 preterm birth cases and 335 term controls from the LIFECODES cohort between 2006 and 2008 (n = 458). Eight urinary PAH metabolites were measured in urine samples collected at up to four study visits (median 12, 18, 24, 34 weeks gestation). Linear and logistic regression were used to model gestational geometric mean PAH biomarker concentrations in relation to preterm birth, birth weight z-score, and small or large for gestational age with adjustment for potential confounders. Effect modification by infant sex was also explored. Odds ratios for preterm birth were elevated for most PAH metabolites but confidence intervals included the null. For most PAH metabolites, a significant inverse association was observed for birth weight for gestational age z-score, and a corresponding increase in the odds of small for gestational age (SGA). For example, an interquartile range increase in 2-hydroxynapthalene (2-NAP) was associated with a significantly lower birth weight z-score (β: 0.22; 95 % CI: 0.36, -0.08) and 1.90 times the odds of SGA (95 %CI: 1.41, 2.55). Further study should aim to determine the extent and mechanisms by which PAH exposure impacts fetal growth.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.